Timely, accurate diagnosis combined with responsible antibiotic use is vital to preserving treatment effectiveness. Diagnostic and antimicrobial stewardship initiatives improve prescribing practices, strengthen surveillance, and promote sustainable antimicrobial use across One Health sectors.
Antimicrobial resistance (AMR) is a growing global health threat that transcends borders, sectors, and species. Misuse and overuse of antibiotics – in patients, animals and plants – are fuelling the selection and spread of resistant bacteria. Addressing this challenge across sectors requires diagnostic stewardship, which ensures treatment decisions are guided by accurate and timely diagnosis, and antimicrobial stewardship, which ensures antimicrobials are used responsibly and appropriately. Together with infection prevention and control, these approaches form the backbone of efforts to preserve antimicrobial effectiveness.
ICARS works with partners globally to co-develop and test context-specific solutions to improve diagnostic and antimicrobial stewardship.
Effective antimicrobial stewardship means using antimicrobials only when necessary and in the right way. In both healthcare and agriculture, ICARS supports countries to implement stewardship strategies that are rooted in local realities.
Diagnostic stewardship ensures that treatment decisions about antimicrobial use are based on accurate, timely diagnostic results. It enhances the effectiveness of antimicrobial stewardship by guiding whether and which antibiotics are truly needed.
Explore ICARS-supported stewardship projects across humans and animals: